FINWIRES · TerminalLIVE
FINWIRES

午盘涨幅最大的股票

By

-- Cue Biopharma (CUE) 股价在宣布与部分投资者签署约 3000 万美元的私募股权融资协议 (PIPE) 并任命林绍利 (Shao-Lee Lin) 为总裁兼首席执行官后,当日飙升 144%。 该公司当日成交量超过 1630 万股,而日均成交量约为 35.6 万股。 Hemab Therapeutics (COAG) 周四宣布,其首次公开募股 (IPO) 定价为每股 18 美元,发行 1680 万股,总募资额为 3.015 亿美元。 该股于周五在纳斯达克全球精选市场开始交易,当日涨幅达 66%,成交量为 187 万股。 摩根士丹利周五发布的一份报告称,Twilio (TWLO) 第一季度业绩超出预期,人工智能驱动的应用案例增长势头强劲,业务表现也强于预期。 股价飙升 20%,盘中交易量超过 444 万股,而日均交易量约为 244 万股。

Price: $34.70, Change: $+19.96, Percent Change: +135.41%

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU